| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44aa549561b3ebbfe98faf807d93b801 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate |
2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91b7ecf39c9d4c8404ae8172f361604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9b3839cd35fe0333403a00fc63fec8e |
| publicationDate |
2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2543815-A1 |
| titleOfInvention |
Multi-site drug delivery platform |
| abstract |
A pharmaceutical composition (10) for administration to a patient body. The composition (10) includes a physiologically-acceptable formulation including at least one active pharmaceutical ingredient, wherein said physiologically-acceptable formulation including said at least one active pharmaceutical ingredient is provided in a delivery form (12), said delivery form (12) being administrable to a patient body through a plurality of administration routes, which include the oral and rectal routes. |
| priorityDate |
2003-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |